Promising results from mouse study lead to expanded trials.

An innovative navel protection solution offers reduced mortality and heavier lamb weights compared to traditional iodine treatment.

Elevate has launched what it bills as a first-of-its-kind proactive healthcare platform in the UK, allowing individuals to detect health risks early.

Transitioning from acute care to outpatient therapy is a major milestone for stroke victims and others recovering from neurological issues. However, leaving the hospital behind introduces a new set of challenges for the patient that can be difficult to overcome.

Deal volumes in the UK tech market may still be a long way from their peak but there’s still been plenty of activity across the sector in the past 12 months.

A couple who kept a 99-day vigil beside their newborn daughter have returned to the Neonatal Intensive Care Unit (NICU) for another new arrival.

Ubisense is pleased to announce the appointment of Kate Edge as its new Chief Financial Officer. With over 15 years of financial leadership experience across major industry players, Kate brings a wealth of expertise and a clear vision to drive Ubisense’s growth, profitability, and operational excellence.

Wilder Sensing, a Somerset-based developer of software for biodiversity monitoring using audio and artificial intelligence (AI), has secured a £300,000 equity investment from the South West Investment Fund, via fund manager The FSE Group.

A groundbreaking navigation device can help people with visual impairment perform a location task as well as sighted people, new research shows.

Novel assay offers a highly sensitive and specific method to detect recombinant proteins containing the human IgG Fc domain.

MFX, Tolemy Bio, and AminoAcids.com join forces to advance model-driven media optimization for cell and gene therapies.

David Brown, Ph.D., to remain active on Healx Board while on secondment to pursue academic research at Trinity College, University of Cambridge.